Global Biopsy Devices Market : Industry Size, Growth, Share and Forecast 2016-2022 by Brisk Insights

According to a recently published report, the Global Biopsy Devices Market is expected to grow at the CAGR of 9% during 2015-2022 and it is estimated to be $XX billion by 2022. The global Biopsy devices market is segmented on the basis of products and geography. The report on global Biopsy devices market forecast 2012-2022 provides detailed overview and predictive analysis of the market.

The market is driven by increasing prevalence of cancer. There is constant need for high quality diagnostic and therapeutic processes. However, such unmet patient needs has forced the companies and governments to work in order to provide better services. Population aging is a major influence on patterns of health care spending in both developed and developing countries. In developed countries such as the U.S. and western European countries, where point of care healthcare services and institutional long-term care services and medcare policies are available. The proportion of aged people using healthcare services is high. The per capita health expenditure on healthcare is higher as compared to other age groups. There is constant pressure on the healthcare services as the number of older people increases. Such factors are driving the biopsy market.

Browse Full Report with Toc : http://www.briskinsights.com/report/global-biopsy-devices-market-forecast-2012-2022

Biopsy market segments include major products such guidance systems, needle based guns, needles, and forceps. Guidance systems have the highest market share amongst all the product. In 2015, guidance systems has 38% market share which expected to remain high till 2022.

Presently, North America and Europe holds the largest market share of the field i.e. more than 60% of the market total. Followed by Asia pacific.

Some of the major market players listed in the report are Angiotech, Boston Scientific, Cardinal Health, Carefusion Corp, etc.

Browse here for all category Reports :...